Search clinical trials for: Leuprolide Depot

Total 874 results

Abbott
Fraktal.com.pl; Med-net.pl

Completed

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) (LEMON)

Lower Urinary Tract Symptoms | Advanced Prostate Cancer

Poland, Ukraine
Enteris BioPharma Inc.
Syneos Health

Completed

A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Endometriosis

Canada
Abbott

Completed

Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer

Prostatic Neoplasm

Belgium, Luxembourg
Takeda

Completed

A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty (PUPIL)

Central Precocious Puberty

China
Colorado Center for Reproductive Medicine

Completed

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF (IntegrinIVF)

Infertility | Endometriosis

United States
National Cancer Institute (NCI)

Terminated

Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer

Prostate Adenocarcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7

United States
Mayo Clinic
National Cancer Institute (NCI)

Terminated

Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

Prostate Adenocarcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Joseph Mccune
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Terminated

GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases (LUPRON)

Lupus Erythematosus, Systemic | Systemic Vasculitis | Lung Disease With Systemic Sclerosis | Isolated Angiitis of Central Nervous System | Lung Disease Interstitial Diffuse

United States
Repros Therapeutics Inc.

Completed

A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata

Uterine Leiomyomata

Poland
Camurus AB

Completed

Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

Prostate Cancer

Finland, Hungary
Thunder Bay Regional Research Institute

Withdrawn

Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

Uterine Leiomyoma

Canada
AbbVie

Completed

A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

Central Precocious Puberty (CPP)

United States, Puerto Rico
Daewoong Pharmaceutical Co. LTD.

Completed

The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

Central Precocious Puberty

Korea, Republic of
M.D. Anderson Cancer Center
TAP Pharmaceutical Products Inc.

Completed

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

Amenorrhea | Premature Ovarian Failure | Ovarian Function Insufficiency

United States
Azidus Brasil

Completed

Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot ® (Leuprorelin Acetate - Abbot)

Healthy

Brazil
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma

United States
GP-Pharm

Completed

Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer

Prostate Cancer

United States
Abbott
M.D. Anderson Cancer Center; Dana-Farber Cancer Institute; Norwood Immunology...

Terminated

A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Lymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease | Mantle Cell Lymphoma

United States
National Cancer Institute (NCI)

Completed

Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer

United States, Canada
AbbVie (prior sponsor, Abbott)

Completed

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

Central Precocious Puberty (CPP) | Precocious | Leuprolide Acetate | Luteinizing Hormone (LH) | Gonadotrophin-releasing Hormone Agonist (GnRHa) | Tanner Staging | Depot Formulation | Suppression of LH | Gonadotrophin-releasing Hormone (GnRH) | Lupron | GnRH Analog | Pediatrics Central Precocious Puberty

United States, Puerto Rico
City of Hope Medical Center
National Cancer Institute (NCI)

Active, not recruiting

Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer

Stage IV Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than Two

United States
Repros Therapeutics Inc.

Terminated

Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids

Uterine Fibroids

United States, Mexico
Astellas Pharma Europe B.V.
Veeda Clinical Research

Completed

Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients (TREMODI)

Prostate Cancer

Belgium
Masonic Cancer Center, University of Minnesota
Minnesota Medical Foundation

Terminated

Preservation of Ovarian Function After Hematopoietic Cell Transplant

Acute Myeloid Leukemia | Myeloproliferative Disorders | Multiple Myeloma | Hodgkin Disease | Non-Hodgkin Lymphoma

United States
University of California, San Francisco
National Cancer Institute (NCI)

Terminated

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

Prostate Adenocarcinoma

United States
National Cancer Institute (NCI)

Completed

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer (TARGET)

Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer

United States
Dana-Farber Cancer Institute
Pfizer; Prostate Cancer Foundation; Myovant Sciences GmbH

Recruiting

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

Prostatic Neoplasms | Prostate Cancer

United States
Ottawa Hospital Research Institute
Tolmar Pharmaceuticals

Recruiting

Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy

Prostate Cancer

Canada
Dana-Farber Cancer Institute
Medivation, Inc.

Completed

Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

Prostate Cancer | Prostate Adenocarcinoma | High Risk Prostate Cancer

United States
Praful Ravi, MB BCHir, MRCP
Eli Lilly and Company; Bayer

Active, not recruiting

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer | Non-metastatic Prostate Cancer

United States
Jonsson Comprehensive Cancer Center
Janssen Inc.

Active, not recruiting

Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer

Recurrent Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation

United States
Antalya IVF

Withdrawn

Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers

Pregnancy

Turkey
University of Washington
Sanofi

Completed

Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer (IAS)

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Recurrent Prostate Cancer

United States
Roswell Park Cancer Institute

Recruiting

Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
University of Ioannina
University of Patras; Tottori University Hospital

Completed

GnRH-a and Pregnancy Rate in In Vitro Fertilization (IVF) Cycles.

Infertility | Endometriosis

Greece
Duke University
Astellas Pharma Inc; Medivation, Inc.

Completed

Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) (STREAM)

Prostate Cancer

United States
Ferring Pharmaceuticals
Memorial Sloan Kettering Cancer Center; Duke Clinical Research Institute

Terminated

A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease (PRONOUNCE)

Prostate Cancer

United States, France, Canada, Czechia, Finland, Germany, Greece, Poland, Russian Federation, Slovakia, South Africa, United Kingdom
Medical University of Lodz

Unknown

Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma

Asthma

Poland
M.D. Anderson Cancer Center
Bristol-Myers Squibb

Completed

Neoadjuvant Ipilimumab in Prostate Cancer

Prostate Cancer

United States
The University of Texas Health Science Center,...
Janssen Scientific Affairs, LLC

Withdrawn

Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer

Prostate Cancer

United States
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH)

Completed

Neurobiology of Bulimia Nervosa

Bulimia Nervosa

United States
GTx

Terminated

Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer (GTx758)

Prostate Cancer

United States
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

Prostate Carcinoma

United States
Eunice Kennedy Shriver National Institute of Child...

Completed

Medical Treatment of Endometriosis-Associated Pelvic Pain

Endometriosis | Pelvic Pain

United States
M.D. Anderson Cancer Center
Bristol-Myers Squibb

Terminated

Ipilimumab + Androgen Depravation Therapy in Prostate Cancer

Prostate Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Prostate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate Cancer

United States
University of California, San Francisco
National Comprehensive Cancer Network

Terminated

Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer

Prostatic Neoplasms | Pelvic Nodal

United States
Roxall Medicina España S.A

Completed

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

Allergic Rhinoconjunctivitis

Spain
University of Virginia

Withdrawn

Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess

Obesity | Polycystic Ovary Syndrome | Hyperandrogenemia

United States

Search clinical trials for: Leuprolide Depot

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ireland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations